Alaunos Therapeutics (TCRT) Insider Trading & Ownership $1.96 -0.06 (-2.97%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Alaunos Therapeutics (NASDAQ:TCRT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.11%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$487,500.00Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$9,513.00 Get TCRT Insider Trade Alerts Want to know when executives and insiders are buying or selling Alaunos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TCRT Insider Buying and Selling by Quarter Ad InvestorPlaceWall Street Icon: “You must get on the right side of this thing”I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.This market shakeup is going to be much more intense. Alaunos Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/1/2023Kevin S Sr. BoyleCEOSell453$21.00$9,513.00 11/29/2022Robert W PostmaDirectorBuy5,000$97.50$487,500.00 (Data available from 1/1/2013 forward) TCRT Insider Trading Activity - Frequently Asked Questions Who is on Alaunos Therapeutics's Insider Roster? The list of insiders at Alaunos Therapeutics includes Kevin S Sr. Boyle, and Robert W Postma. Learn more on insiders at TCRT. What percentage of Alaunos Therapeutics stock is owned by insiders? 5.11% of Alaunos Therapeutics stock is owned by insiders. Learn more on TCRT's insider holdings. Which Alaunos Therapeutics insiders have been selling company stock? The following insider sold TCRT shares in the last 24 months: Kevin S Sr. Boyle ($9,513.00). How much insider selling is happening at Alaunos Therapeutics? Insiders have sold a total of 453 Alaunos Therapeutics shares in the last 24 months for a total of $9,513.00 sold. Alaunos Therapeutics Key ExecutivesMr. Dale Curtis Hogue Jr. (Age 54)Interim CEO & Director Ms. Melinda Lackey (Age 47)Senior VP of Legal, Administration & Secretary Compensation: $625.12kMr. Michael Wong (Age 44)Vice President of Finance & Principal Accounting Officer More Insider Trading Tools from MarketBeat Related Companies Kazia Therapeutics Insider Trades Talphera Insider Trades Sensei Biotherapeutics Insider Trades Turnstone Biologics Insider Trades Kiora Pharmaceuticals Insider Trades Indaptus Therapeutics Insider Trades Eagle Pharmaceuticals Insider Trades BioCardia Insider Trades Cyclerion Therapeutics Insider Trades Vaccinex Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:TCRT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TCRT Stock Alerts